Microalbuminuria: Undervalued As A Risk Assessment Tool

Hermann Haller

Hermann Haller tells Peter Goodwin about the significant health risks—including for renal disease, myocardial infarction and stroke—which are going undetected across Europe because doctors are not testing their patients who have hypertension for microalbuminuria. He discusses the findings of a European Society of Hypertension survey revealing widespread ignorance among general practitioners, cardiologists and diabetologists.

LISTEN

[audio:https://www.audiomedica.com/podcasting/cardio/090615HermannHallerPODCAST.mp3]